2016 tables: Institutions - Nature & Science - corporate

The 2016 tables are based on Nature Index data from 1 January 2015 to 31 December 2015.

Table criteria

# Institution Share 2015 Count 2015
1 IBM Corporation, United States of America (USA) 3.14 7
2 Merck & Co., Inc., United States of America (USA) 2.70 6
3 Bristol-Myers Squibb (BMS), United States of America (USA) 1.69 3
4 Alphabet Inc., United States of America (USA) 1.42 3
5 Amgen Inc., United States of America (USA) 1.03 5
6 Cellular Research, Inc., United States of America (USA) 1.00 1
7 Johnson & Johnson, United States of America (USA) 0.86 4
8 Facebook, Inc., United States of America (USA) 0.83 1
9 Ionis Pharmaceuticals, Inc., United States of America (USA) 0.82 3
10 Gilead Sciences, Inc., United States of America (USA) 0.77 1
11 D. E. Shaw Research, United States of America (USA) 0.77 2
12 Carbon3D, Inc., United States of America (USA) 0.74 1
13 Natera, Inc., United States of America (USA) 0.67 1
14 Leidos Holdings, Inc., United States of America (USA) 0.61 10
15 Profectus Biosciences, Inc., United States of America (USA) 0.58 2
16 Pfizer Inc., United States of America (USA) 0.56 2
17 Tekmira Pharmaceuticals Corp., Canada 0.50 1
18 NovoBiotic Pharmaceuticals, LLC, United States of America (USA) 0.48 1
19 Pacific Biosciences of California, Inc., United States of America (USA) 0.45 2
20 Illumina, Inc., United States of America (USA) 0.38 4
21 Exxon Mobil Corporation (ExxonMobil), United States of America (USA) 0.35 3
22 Microsoft Corporation, United States of America (USA) 0.29 4
23 AnimalScan Advanced Veterinary Imaging, United States of America (USA) 0.27 1
24 Orion Genomics, United States of America (USA) 0.26 1
25 Fluidigm Corporation, United States of America (USA) 0.25 1
26 Sangamo Therapeutics Inc., United States of America (USA) 0.24 1
27 Protiva Biotherapeutics, Inc., Canada 0.23 1
28 Cadre Research Labs (CRL), United States of America (USA) 0.22 1
29 Azimuth Corporation, United States of America (USA) 0.20 1
30 Tempero Pharmaceuticals, United States of America (USA) 0.18 1
31 Regeneron Pharmaceuticals, Inc., United States of America (USA) 0.17 1
32 Atmospheric and Environmental Research, Inc. (AER), United States of America (USA) 0.17 1
33 Kemxtree LLC, United States of America (USA) 0.14 1
33 MS Bioworks LLC, United States of America (USA) 0.14 1
33 Aduro BioTech, Inc., United States of America (USA) 0.14 1
34 Coleman Technologies, Inc. (CTI), United States of America (USA) 0.13 1
35 Thermo Fisher Scientific Inc., United States of America (USA) 0.13 3
36 BioNano Genomics, United States of America (USA) 0.13 1
36 Xerox Corporation, United States of America (USA) 0.13 1
36 DSM Environmental Services, Inc., United States of America (USA) 0.13 1
37 Bear Fight Institute (BFI), United States of America (USA) 0.12 3
38 Bioinfo, Canada 0.12 2
39 Xenon Pharmaceuticals Inc., Canada 0.11 1
39 Personal Genome Diagnostics, Inc. (PGDx), United States of America (USA) 0.11 1
40 Hysitron, Inc., United States of America (USA) 0.11 1
40 Taconic Biosciences, Inc., United States of America (USA) 0.11 1
40 Codex BioSolutions, Inc., United States of America (USA) 0.11 1
40 LMI, United States of America (USA) 0.11 1
40 Synta Pharmaceuticals Corp., United States of America (USA) 0.11 1
41 Vir Biotechnology, Inc., United States of America (USA) 0.10 1
42 Prism Computational Sciences, Inc., United States of America (USA) 0.09 1
42 Dow Inc., United States of America (USA) 0.09 1
42 PolyK Technologies, LLC, United States of America (USA) 0.09 1
43 TRIM-edicine, Inc., United States of America (USA) 0.08 1
44 Advanced Cell Technology (ACT), United States of America (USA) 0.08 1
45 KinetX Aerospace, Inc., United States of America (USA) 0.07 1
46 Genesis Biosciences, Inc., United States of America (USA) 0.07 1
47 Biogen Inc., United States of America (USA) 0.07 3
48 Computational Physics, Inc., United States of America (USA) 0.07 3
49 Bruker Corporation, United States of America (USA) 0.06 1
50 Malin Space Science Systems (MSSS), United States of America (USA) 0.06 1

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.